These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 26323409)

  • 1. Dosing Guidelines of Aminoglycosides in Neonates: A Balance Between Physiology and Feasibility.
    Allegaert K; Cossey V; van den Anker JN
    Curr Pharm Des; 2015; 21(39):5699-704. PubMed ID: 26323409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug monitoring of aminoglycosides in neonates.
    Touw DJ; Westerman EM; Sprij AJ
    Clin Pharmacokinet; 2009; 48(2):71-88. PubMed ID: 19271781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Extended-interval aminoglycoside administration for children: a meta-analysis.
    Contopoulos-Ioannidis DG; Giotis ND; Baliatsa DV; Ioannidis JP
    Pediatrics; 2004 Jul; 114(1):e111-8. PubMed ID: 15231982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adaptation in neonatology of the once-daily concept of aminoglycoside administration: evaluation of a dosing chart for amikacin in an intensive care unit.
    Langhendries JP; Battisti O; Bertrand JM; François A; Kalenga M; Darimont J; Scalais E; Wallemacq P
    Biol Neonate; 1998 Nov; 74(5):351-62. PubMed ID: 9742264
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aminoglycoside extended interval dosing in neonates is safe and effective: a meta-analysis.
    Nestaas E; Bangstad HJ; Sandvik L; Wathne KO
    Arch Dis Child Fetal Neonatal Ed; 2005 Jul; 90(4):F294-300. PubMed ID: 15857879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical pharmacokinetics of antibacterial drugs in neonates.
    Paap CM; Nahata MC
    Clin Pharmacokinet; 1990 Oct; 19(4):280-318. PubMed ID: 2208898
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Once-daily dosing of aminoglycosides: review and recommendations for clinical practice.
    Freeman CD; Nicolau DP; Belliveau PP; Nightingale CH
    J Antimicrob Chemother; 1997 Jun; 39(6):677-86. PubMed ID: 9222035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antibacterial dosing in intensive care: pharmacokinetics, degree of disease and pharmacodynamics of sepsis.
    Roberts JA; Lipman J
    Clin Pharmacokinet; 2006; 45(8):755-73. PubMed ID: 16884316
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The efficacy and toxicity of two dosing-regimens of amikacin in neonates with sepsis.
    Abdel-Hady E; El Hamamsy M; Hedaya M; Awad H
    J Clin Pharm Ther; 2011 Feb; 36(1):45-52. PubMed ID: 21198719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aminoglycosides in hemodialysis patients: is the current practice of post dialysis dosing appropriate?
    O'Shea S; Duffull S; Johnson DW
    Semin Dial; 2009; 22(3):225-30. PubMed ID: 19386073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A survey of extended-interval aminoglycoside dosing practices in United States adult cystic fibrosis programs.
    Prescott WA
    Respir Care; 2014 Sep; 59(9):1353-9. PubMed ID: 24782555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New dosing strategies for antibacterial agents in the neonate.
    de Hoog M; Mouton JW; van den Anker JN
    Semin Fetal Neonatal Med; 2005 Apr; 10(2):185-94. PubMed ID: 15701583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics of aminoglycosides in the newborn.
    van den Anker JN; Allegaert K
    Curr Pharm Des; 2012; 18(21):3114-8. PubMed ID: 22564303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of extended-interval aminoglycoside dosing strategies for the treatment of moderate-to-severe infections encountered in critically ill surgical patients.
    Mueller EW; Boucher BA
    Surg Infect (Larchmt); 2009 Dec; 10(6):563-70. PubMed ID: 20035611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The amikacin research program: a stepwise approach to validate dosing regimens in neonates.
    Smits A; Kulo A; van den Anker J; Allegaert K
    Expert Opin Drug Metab Toxicol; 2017 Feb; 13(2):157-166. PubMed ID: 27623706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of aminoglycosides in elderly patients. Pharmacokinetic and clinical considerations.
    Mörike K; Schwab M; Klotz U
    Drugs Aging; 1997 Apr; 10(4):259-77. PubMed ID: 9108987
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology.
    Miller MM; Burton ME; Johnson PN; Miller JL
    Am J Health Syst Pharm; 2014 Dec; 71(24):2108-9. PubMed ID: 25465576
    [No Abstract]   [Full Text] [Related]  

  • 18. Exploration of once-daily dosing of aminoglycosides through Bayesian simulation.
    Garrelts JC
    Pharmacotherapy; 1996; 16(2):286-94. PubMed ID: 8820474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of once-daily versus pharmacokinetic dosing of aminoglycosides in elderly patients.
    Koo J; Tight R; Rajkumar V; Hawa Z
    Am J Med; 1996 Aug; 101(2):177-83. PubMed ID: 8757358
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Once-daily aminoglycoside dosing: An update on current literature.
    Stankowicz MS; Ibrahim J; Brown DL
    Am J Health Syst Pharm; 2015 Aug; 72(16):1357-64. PubMed ID: 26246292
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.